InvestorsHub Logo
Followers 165
Posts 19813
Boards Moderated 2
Alias Born 12/09/2004

Re: Rubyred77 post# 400357

Saturday, 01/28/2023 3:18:07 PM

Saturday, January 28, 2023 3:18:07 PM

Post# of 462843
Seems to me that the "improvements" of Lecanemab over Aducanumab are small. There are still the same issues of administration and adverse events.

The market saw what happened with Aducanumab and it would appear that the market expects a similar outcome.

If investing was easy, everyone would be rich by now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News